Chemsex is the use of certain drugs to enhance or prolong sex, usually in group or hook‑up settings, and it matters because it’s now seen as a serious public‑health and mental‑health issue in many cities worldwide.

What is chemsex?

  • The word combines “chemical” and “sex” and usually refers to sex that involves psychoactive or disinhibiting drugs, often taken intentionally to change how sex feels or how long it lasts.
  • It has been most commonly described among gay, bisexual and other men who have sex with men (including some trans people), especially in app‑based hook‑up cultures, though anyone can be involved.
  • Common “chems” include stimulants like crystal methamphetamine, mephedrone and cocaine, and drugs like GBL/GHB; they are often combined, which sharply increases risks.

In many communities, people will also refer to this as “party and play” (PnP) or similar slang, but the core idea is the same: using drugs specifically around sex.

Why does chemsex matter?

1. Health and overdose risks

  • Stimulants and GHB/GBL can cause overdose, loss of consciousness, breathing problems, heart strain and, in some cases, death; London police data suggest chemsex‑related drugs were linked to around three deaths a month in 2023 in that city alone.
  • Emergency services in some major cities now report daily or near‑daily callouts related to chemsex drugs, showing it is no longer a rare phenomenon but a routine burden on health systems.
  • Mixing multiple chems, or combining them with alcohol or certain medications (including some HIV treatments or mental‑health meds), can magnify toxicity and make dosing unpredictable.

2. Sexual health and HIV/STI concerns

  • Because chems lower inhibitions, people may have longer sessions with multiple partners, use condoms less consistently, or find it harder to negotiate boundaries, which can increase HIV and STI transmission risks.
  • Public‑health organisations describe chemsex as a “growing global public health concern” precisely because it sits at the intersection of drug use, HIV, hepatitis and other STIs.
  • Some clinics now report that a significant share of their drug‑related presentations or sexual‑health complications are linked to chemsex, which pushes services to adapt specifically to this pattern of use.

3. Mental health, consent and safety

  • Episodes can last many hours or days, often with little sleep or food, which can worsen anxiety, low mood, psychosis‑like experiences or comedowns afterwards.
  • Blurred memory and impaired judgment can make it harder to give or verify informed consent, and some people report regretted encounters, coercion or assault that they only piece together after the fact.
  • Shame and stigma—around sexuality, drug use or both—can stop people from seeking help early, allowing problems to deepen before they reach services.

4. Why it’s a “trending topic” now

  • Recent investigations in the UK and Europe have described chemsex as a “silent crisis”, with rising deaths and ambulance callouts yet relatively little mainstream attention.
  • In March 2026, for example, court reports about former UK MP Crispin Blunt mentioned that he attended chemsex parties and possessed drugs like crystal meth and GBL, which pushed the term back into the political news cycle.
  • International forums and symposia dedicated to chemsex—bringing together responders, clinicians, researchers and community workers—have grown, reflecting recognition that this is now a structured public‑health topic rather than just a niche subculture.

How people are responding (forums, services, harm reduction)

  • Dedicated chemsex forums and online groups now connect hundreds of responders, peer supporters, clinicians and people with lived experience to share strategies, research and practical support.
  • Harm‑reduction organisations emphasise non‑judgmental care: asking open questions about sex and drug use, supporting people with information, condoms, HIV prevention (like PrEP), and safer‑use advice rather than only telling them to stop.
  • New guidelines for clinicians encourage frank, stigma‑free conversations so patients feel safe talking about chemsex, which is often the only way to spot risks and offer timely help.

Mini FAQ: key points at a glance

  • Is chemsex only about gay men?
    No, but most research and services have focused on gay, bi and other men who have sex with men, where the pattern was first documented in detail.
  • Is this mainly a “party” thing or a medical issue?
    It’s both: people describe pleasure, intimacy and community, but health systems now see clear patterns of overdose, mental‑health crises and infections that make it a significant medical and social issue.
  • Why does it keep showing up in the news?
    Because of clusters of deaths, criminal cases linked to chemsex parties, and evidence that some cities are seeing a wave of HIV or other harms associated with these gatherings.
  • What’s the bottom line?
    Chemsex matters because it sits at the crossroads of sexuality, drugs, consent and public health, and ignoring it leaves people at higher risk and services unprepared.

TL;DR: What is chemsex and why does it matter? It is using specific drugs around sex to change or intensify the experience, and it matters today because it is driving a visible but often “silent” crisis in overdose, HIV/STIs and mental health, while also raising hard questions about consent, stigma and how health systems should respond.

Information gathered from public forums or data available on the internet and portrayed here.